• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Gevo Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8/29/24 9:00:25 AM ET
    $GEVO
    Major Chemicals
    Industrials
    Get the next $GEVO alert in real time by email
    false 0001392380 0001392380 2024-08-28 2024-08-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): August 28, 2024

     

     

    Gevo, Inc.

    (Exact name of registrant as specified in its charter)

     

     

    Delaware 001-35073 87-0747704
    (State or other jurisdiction (Commission File Number) (IRS Employer
    of incorporation)   Identification No.)

     

    345 Inverness Drive South, Building C, Suite 310
    Englewood
    , CO 80112

    (Address of principal executive offices) (Zip Code)

     

    Registrant’s telephone number, including area code: (303) 858-8358

     

    N/A

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading symbol   Name of exchange on which registered
    Common Stock, par value $0.01 per share   GEVO   Nasdaq Capital Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

     

     

     

     

     

    Item 3.01.Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

     

    On August 28, 2024, Gevo, Inc. (the “Company”) received a letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) granting the Company an additional 180 calendar days, or until February 24, 2025, to regain compliance with the $1.00 per share minimum bid price requirement required for continued listing on the Nasdaq Capital Market pursuant to Nasdaq Marketplace Rule 5550(a)(2) (the “Minimum Bid Price Rule”).

     

    As previously reported, on February 29, 2024, the Company received a notification letter from the Staff advising the Company that for 30 consecutive trading days preceding the date of the notice from Nasdaq, the bid price of the Company’s common stock had closed below the $1.00 per share minimum required for continued listing on the Nasdaq Capital Market pursuant to the Minimum Bid Price Rule. The Company was provided an initial 180 calendar days, or until August 27, 2024, to regain compliance with the Minimum Bid Price Rule. The Nasdaq determination to grant the second compliance period was based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the bid price requirement, and the Company’s written notice of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary.

     

    To regain compliance, the bid price of the Company’s common stock must close at or above $1.00 per share for a minimum of ten consecutive business days at any time during the second 180-day compliance period. The Company intends to monitor the closing bid price of its common stock and may, if appropriate, consider implementing available options, including submitting a reverse stock split for approval by the Company’s stockholders. If a reverse stock split is approved by the stockholders of the Company, the Company’s Board of Directors will consider whether a reverse stock split is necessary and would facilitate the Company regaining compliance with the Minimum Bid Price Rule by February 24, 2025. There can be no assurance that the Company will be able to regain compliance with the Minimum Bid Price Rule or maintain compliance with the other listing requirements necessary for the Company to maintain the listing of its common stock on the Nasdaq Capital Market.

     

    The notice from Nasdaq has no effect on the listing of the Company’s common stock at this time and the Company’s common stock will continue to trade on the Nasdaq Capital Market under the symbol “GEVO”.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      GEVO, INC.
         
    Dated: August 29, 2024 By: /s/ E. Cabell Massey
        E. Cabell Massey
        Vice President, Legal and Corporate Secretary

     

     

     

    Get the next $GEVO alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GEVO

    DatePrice TargetRatingAnalyst
    8/21/2023$2.00Market Perform
    Northland Capital
    12/14/2022$2.25Neutral
    UBS
    10/19/2022$2.29Hold
    Jefferies
    2/9/2022$5.00Buy
    Citigroup
    8/24/2021$10.00Buy
    Stifel
    More analyst ratings

    $GEVO
    SEC Filings

    View All

    SEC Form 144 filed by Gevo Inc.

    144 - Gevo, Inc. (0001392380) (Subject)

    8/18/25 4:29:29 PM ET
    $GEVO
    Major Chemicals
    Industrials

    Amendment: SEC Form 10-K/A filed by Gevo Inc.

    10-K/A - Gevo, Inc. (0001392380) (Filer)

    8/15/25 4:05:30 PM ET
    $GEVO
    Major Chemicals
    Industrials

    SEC Form 10-Q filed by Gevo Inc.

    10-Q - Gevo, Inc. (0001392380) (Filer)

    8/11/25 4:36:20 PM ET
    $GEVO
    Major Chemicals
    Industrials

    $GEVO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $GEVO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Gevo Reports Second Quarter 2025 Financial Results

    Achieves Positive Net Income in the Second Quarter and Positive Adjusted EBITDA1 for the Second Quarter and Six Months Ended June 30, 2025  Positive Net Income Attributable to Gevo of $2.1 million in the Second QuarterPositive Adjusted EBITDA1 of $17 million in the Second QuarterRevenues Increased $14 million Quarter-Over-QuarterPositive Earnings per Share Attributable to Gevo of $0.01 for the Second QuarterResults Driven by Successful Execution on Low-Carbon Ethanol and Carbon Capture Acquisition, First Sales of Clean Fuel Production Credits ENGLEWOOD, Colo., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) ("Gevo", the "Company", "we", "us" or "our"), a leading develo

    8/11/25 4:01:00 PM ET
    $GEVO
    Major Chemicals
    Industrials

    Gevo to Report Second Quarter 2025 Financial Results on August 11, 2025

    ENGLEWOOD, Colo., July 24, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) announced today that it will host a conference call on August 11, 2025, at 4:30 p.m. ET (2:30 p.m. MT) to report its financial results for the second quarter that ended June 30, 2025. To participate in the live call, please register through the following event weblink: https://register-conf.media-server.com/register/BI837becc646fa4780899cbd8ed1b21b9a After registering, participants will be provided with a dial-in number and pin. To listen to the conference call (audio only), please register through the following event weblink: https://edge.media-server.com/mmc/p/u9fuak7q A webcast replay will be available two

    7/24/25 9:00:00 AM ET
    $GEVO
    Major Chemicals
    Industrials

    Gevo Sells Carbon Credits from North Dakota Asset

    ENGLEWOOD, Colo., July 21, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) is pleased to announce that it is selling carbon abatement into the market for the first time. To support decarbonization and to mitigate its corporate travel emissions, the buyer, a global financial and technology company, purchased high-integrity durable carbon removal credits, known as CORCs (or CO2 Removal Certificates), that are Puro.earth-certified and are ready to retire immediately. CORCs provide true carbon abatement, with a volume of actual carbon dioxide permanently removed from circulation, which offsets the effect of emissions. Selling high-integrity CORCs is core to Gevo's strategy, with the rapid

    7/21/25 9:00:00 AM ET
    $GEVO
    Major Chemicals
    Industrials

    CFO Agiri Oluwagbemileke Yusuf sold $93,942 worth of shares (57,651 units at $1.63), decreasing direct ownership by 17% to 277,835 units (SEC Form 4)

    4 - Gevo, Inc. (0001392380) (Issuer)

    8/21/25 6:00:09 PM ET
    $GEVO
    Major Chemicals
    Industrials

    Chief Cust Mkt & Brnd Officer Shafer Andrew sold $7,916 worth of shares (5,000 units at $1.58), decreasing direct ownership by 2% to 325,620 units (SEC Form 4)

    4 - Gevo, Inc. (0001392380) (Issuer)

    8/21/25 6:00:05 PM ET
    $GEVO
    Major Chemicals
    Industrials

    Director Mize Gary W. exercised 224,639 shares at a strike of $0.67 and sold $153,258 worth of shares (91,459 units at $1.68), increasing direct ownership by 52% to 388,326 units (SEC Form 4)

    4 - Gevo, Inc. (0001392380) (Issuer)

    8/19/25 6:00:05 PM ET
    $GEVO
    Major Chemicals
    Industrials

    $GEVO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Northland Capital initiated coverage on Gevo with a new price target

    Northland Capital initiated coverage of Gevo with a rating of Market Perform and set a new price target of $2.00

    8/21/23 9:21:52 AM ET
    $GEVO
    Major Chemicals
    Industrials

    UBS initiated coverage on Gevo with a new price target

    UBS initiated coverage of Gevo with a rating of Neutral and set a new price target of $2.25

    12/14/22 7:48:29 AM ET
    $GEVO
    Major Chemicals
    Industrials

    Jefferies initiated coverage on Gevo with a new price target

    Jefferies initiated coverage of Gevo with a rating of Hold and set a new price target of $2.30

    10/19/22 8:39:11 AM ET
    $GEVO
    Major Chemicals
    Industrials

    $GEVO
    Financials

    Live finance-specific insights

    View All

    Gevo Reports Second Quarter 2025 Financial Results

    Achieves Positive Net Income in the Second Quarter and Positive Adjusted EBITDA1 for the Second Quarter and Six Months Ended June 30, 2025  Positive Net Income Attributable to Gevo of $2.1 million in the Second QuarterPositive Adjusted EBITDA1 of $17 million in the Second QuarterRevenues Increased $14 million Quarter-Over-QuarterPositive Earnings per Share Attributable to Gevo of $0.01 for the Second QuarterResults Driven by Successful Execution on Low-Carbon Ethanol and Carbon Capture Acquisition, First Sales of Clean Fuel Production Credits ENGLEWOOD, Colo., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) ("Gevo", the "Company", "we", "us" or "our"), a leading develo

    8/11/25 4:01:00 PM ET
    $GEVO
    Major Chemicals
    Industrials

    Gevo to Report Second Quarter 2025 Financial Results on August 11, 2025

    ENGLEWOOD, Colo., July 24, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) announced today that it will host a conference call on August 11, 2025, at 4:30 p.m. ET (2:30 p.m. MT) to report its financial results for the second quarter that ended June 30, 2025. To participate in the live call, please register through the following event weblink: https://register-conf.media-server.com/register/BI837becc646fa4780899cbd8ed1b21b9a After registering, participants will be provided with a dial-in number and pin. To listen to the conference call (audio only), please register through the following event weblink: https://edge.media-server.com/mmc/p/u9fuak7q A webcast replay will be available two

    7/24/25 9:00:00 AM ET
    $GEVO
    Major Chemicals
    Industrials

    Gevo Reports First Quarter 2025 Financial Results

    Quarterly Revenue Increased $25 Million Compared to First Quarter of 2024 Due to Strategic Growth Initiatives  Further Revenue and Adjusted EBITDA1 Growth is Expected in 2025  Gevo to Host Conference Call Today at 4:30 p.m. ET ENGLEWOOD, Colo., May 13, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) ("Gevo", the "Company", "we", "us" or "our"), a leading developer of cost-effective, renewable hydrocarbon fuels and chemicals that also can deliver significant carbon emission abatement, today announced financial results for the first quarter ended March 31, 2025. Recent Corporate Highlights: Continuing on a Path to Positive Adjusted EBITDA1  Revenue and Adjusted EBITDA growth: Total op

    5/13/25 4:01:00 PM ET
    $GEVO
    Major Chemicals
    Industrials

    $GEVO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Gevo Inc.

    SC 13G/A - Gevo, Inc. (0001392380) (Subject)

    11/12/24 4:02:11 PM ET
    $GEVO
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Gevo Inc.

    SC 13G/A - Gevo, Inc. (0001392380) (Subject)

    11/4/24 11:58:10 AM ET
    $GEVO
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Gevo Inc.

    SC 13G/A - Gevo, Inc. (0001392380) (Subject)

    7/8/24 4:32:39 PM ET
    $GEVO
    Major Chemicals
    Industrials

    $GEVO
    Leadership Updates

    Live Leadership Updates

    View All

    Gevo Appoints Industry Veteran James Barber, Ph.D. to Board of Directors

    ENGLEWOOD, Colo., May 27, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO), a leader in sustainable aviation fuel and renewable chemicals, announced today the appointment of James J. Barber, Ph.D., to its Board of Directors. Dr. Barber brings decades of executive leadership and board experience in public and private companies including fuels, chemicals, biobased materials, micro-optics, carbon nanofibers, joint ventures and licensing. Dr. Barber currently serves on the board of directors of Graham Corporation (NYSE:GHM), where he chairs the Compensation Committee and is a member of the Audit and Nomination and Governance Committees. Dr. Barber holds a Ph.D. in Organic Chemistry from the

    5/27/25 4:10:00 PM ET
    $GEVO
    $GHM
    Major Chemicals
    Industrials
    Industrial Machinery/Components

    Gevo Promotes Leke Agiri to Chief Financial Officer

    ENGLEWOOD, Colo., May 27, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO), is pleased to announce the appointment of Oluwagbemileke (Leke) Agiri as Chief Financial Officer, effective as of May 21, 2025. Mr. Agiri succeeds L. Lynn Smull, who will continue with the Company in a new role as Executive Vice President and Senior Advisor to the Chief Executive Officer, focusing on strategic initiatives and to aide and support a seamless transition. Mr. Agiri brings extensive experience and leadership in corporate finance, capital markets, and strategic growth, both organic and inorganic. Since joining Gevo in August 2022, he has served in key leadership roles, most recently as Executive Vice P

    5/27/25 4:01:00 PM ET
    $GEVO
    Major Chemicals
    Industrials

    Gevo Announces Appointment of Katie Ellet to Board of Directors

    ENGLEWOOD, Colo., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) is pleased to announce that Katie Ellet has been appointed to its board of directors as of January 2, 2024. Ms. Ellet serves as president, Hydrogen Energy and Mobility for North America at Air Liquide, a world leader in gases, technologies and services for Industry and Health, and a global innovator in low carbon hydrogen production. She has held a wide variety of leadership roles in the chemical and energy fields for the last 27 years. "We are honored to have Katie join our Board of Directors," said Dr. Patrick Gruber, CEO of Gevo. "She has a demonstrated record of technology expertise, market knowledge, and inn

    1/3/24 4:05:00 PM ET
    $GEVO
    Major Chemicals
    Industrials